Feb. 6, 2019 / PRZen
/ LAS VEGAS -- TRICCAR Holdings, Inc., aka, TRICCAR, today announced an addition to its Board of Directors and Scientific Advisory Board.
Steve Hayden joins TRICCAR's Board of Directors as an outside director. Mr. Hayden is a well-known figure in the global advertising industry, having most recently served as Vice Chairman and Chief Creative Officer of Ogilvy Worldwide.
Hayden is one of the most important figures of the late twentieth century advertising, leading creative teams at both Chiat/Day and BBDO on the Apple Computer account. He was the co-creator, along with Lee Clow, of Apple Inc.'s 1984
commercial that launched the Macintosh. Following the account's move to BBDO, Hayden became the Chairman and CEO of BBDO's West Coast operations. The Hayden-led BBDO managed the Apple account for more than a decade, winning hundreds of awards for creative excellence and dozens more for effectiveness, including the Grand Effie for the launch of the Apple Powerbook. BBDO helped Apple become the #1 manufacturer of personal computers in the world, reclaiming the lead from IBM and Compaq in late 1992. The agency tripled in size during Hayden's tenure.
In 1994, Hayden moved to Ogilvy to head the IBM account, which had moved to Ogilvy in the single largest account consolidation in advertising history. Success on IBM propelled Ogilvy to a decade of growth and prosperity and Hayden contributed to award-winning work for diverse clients including American Express, Motorola, Dove, Cisco and SAP.
"We are pleased to have Steve Hayden join TRICCAR's Board of Directors," said Bill Townsend, President and CEO. "As a marketing-driven bioceutical company, being able to tap into Mr. Hayden's vast experience in connecting with consumers is a once in a lifetime opportunity for any company. We're thrilled he chose TRICCAR to lend his expertise."
TRICCAR is a Las Vegas, Nevada-based bioceutical company creating treatments that support the health of those suffering from the world's most common diseases, including, obesity, cancer, pain, diabetic neuropathy, calcium deficiency, and trigeminal neuralgia. The Company competes in markets estimated at $1 trillion in annual sales for human and animal formulations.
For additional information on TRICCAR, please visit http://www.triccar.com
Follow the full story here: https://przen.com/pr/33286072